Ramon Lugo-Sanchez, MD
Neuromusculoskeletal Medicine & OMM · Miramar, FLNPI 1134357957
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,430 of the $6,253 with a category attached, or 86.8%. It is spread thinly across 43 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,062 and has fallen 66.2% since, to $697 in 2025. Among neuromusculoskeletal medicine & omm clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 293 payments — averaging $21.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Medical Device Business Services, Inc.$1K
- Neurocrine Biosciences, Inc.$960
- AstraZeneca$322
- UCB, Inc.$248
- Acadia Pharmaceuticals Inc$238
- plus $2K from 37 others
What the payments were for
- Travel & lodging$82313%
- Food & beverage$5,43087%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STRATAFIX$949
- INGREZZA$234
- NURTEC ODT$114
How this compares
$6,253 in reported general payments places this provider in the 90th percentile of 41 neuromusculoskeletal medicine & omm providers in Florida.
See all neuromusculoskeletal medicine & omm providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GammaplexImmun Glob G(Igg)/Gly/Iga 0-50 | 29 | $340,875 |
| GammakedImmune Globul G/Gly/Iga Avg 46 | 18 | $294,797 |
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 13 | $223,563 |
| NuplazidPimavanserin Tartrate | 43 | $208,567 |
| GocovriAmantadine Hcl | 20 | $88,468 |
| NeuproRotigotine | 37 | $46,071 |
| RytaryCarbidopa/Levodopa | 33 | $40,798 |
| Rasagiline Mesylate | 48 | $12,379 |
| Entacapone | 55 | $12,246 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 497 | $11,964 |
| Aimovig AutoinjectorErenumab-Aooe | 13 | $9,940 |
| Memantine Hcl | 236 | $6,292 |
| Rivastigmine | 25 | $5,331 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 125 | $4,656 |
| Ropinirole ErRopinirole Hcl | 21 | $3,141 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Acadia Pharmaceuticals IncNuplazid | $238 | $208,56743 claims |
| MDD US Operations, LLCGocovri | $23 | $88,46820 claims |
| UCB, Inc.Neupro | $248 | $46,07137 claims |
| Amneal Pharmaceuticals LLCRytary | $16 | $40,79833 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 41 neuromusculoskeletal medicine & omm providers in Florida.
Other neuromusculoskeletal medicine & omm in Miramar
- Patricio EspinosaBoca Raton$245K
- Hassan BitarBrandon$12K
- Mohamad SalehTemple Terrace$11K
- Issachar DevineLake Mary$6K
- Chitto SarkarPort St Lucie$2K
- Glenn ChapmanBoynton Beach$2K
- Jesse KemmerlinSouth Miami$2K
- Jonathan QuinonezRiverview$1K
- Joel SteinFort Lauderdale$1K
- Xiawei ZhongOrlando$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.